Welcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol Myers Squibb and more are set to report their Q2 ...
Welcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol Myers Squibb and more are …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
GSK’s first lung cancer approval, a new IPO path and more
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
Anthropic deepens work with rare disease drugs
Pharma tries to tamp down broad China restrictions
